Dr. Daniel Weinbuch is Business Development Manager at Coriolis Pharma. He holds a Ph.D. from the Leiden University (The Netherlands) in Biopharmaceutical Sciences. His research focused on the topic “pharmaceutical aspects of subvisible particles in protein formulations”, where he (co-)authored eight peer-reviewed publications. Daniel works for Coriolis Pharma since 2013. His previous work experience includes positions at Ratiopharm (now Teva) in Germany and Boehringer Ingelheim U.S. and Japan.